Lenox Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-5
| Closed | – | – | 913 |
|
2021
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 990 |
|
2020
Q2 | – | Sell |
-45
| Closed | -$4K | – | 727 |
|
2020
Q1 | $4K | Buy |
+45
| New | +$4K | ﹤0.01% | 458 |
|
2019
Q2 | – | Sell |
-35
| Closed | -$3K | – | 522 |
|
2019
Q1 | $3K | Buy |
+35
| New | +$3K | ﹤0.01% | 467 |
|